Anavex Life Sciences Corp. (AVXL)
4.34
-0.06
(-1.36%)
USD |
NASDAQ |
Dec 08, 16:00
4.44
+0.10
(+2.30%)
After-Hours: 07:30
Anavex Life Sciences Shareholders Equity (Quarterly): 94.87M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Vanda Pharmaceuticals, Inc. | 466.00M |
| ADMA Biologics, Inc. | 431.19M |
| Aldeyra Therapeutics, Inc. | 49.24M |
| ACADIA Pharmaceuticals, Inc. | 917.27M |
| CorMedix, Inc. | 374.13M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 103.82M |
| Total Liabilities (Quarterly) | 8.946M |
| Current Ratio | 11.60 |